For Investors

Due diligence intelligence for life sciences investors.

Evaluate repurposing narratives with graded evidence rather than press releases. We publish insufficient-evidence records alongside strong signals to maintain credibility.

Platform capabilities

Evidence confidence scoring (0–100)
Approved vs. repurposing signal distinction
Audit trail for data provenance
Last verified timestamps
No diagnostic or treatment claims

Repositioning Intelligence is a research and decision-support tool for qualified professionals. It does not provide medical advice, diagnosis, or treatment recommendations. Contact your organization's medical affairs team for clinical decisions.